Aichi Cancer Center ( Site 3307)

Nagoya, Aichi-ken 464-8681

0 studies enrolling now · 1 studies all time

What they study most

Gastroesophageal Cancer

Studies at this site

• A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) — Running, not enrolling